- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 223/12 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 223/12
Total number of patents in this class: 62
10-year publication summary
|
5
|
4
|
7
|
6
|
3
|
3
|
4
|
2
|
2
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oryzon Genomics S.A. | 103 |
5 |
| Syngenta Participations AG | 4970 |
3 |
| BioMarin Pharmaceutical Inc. | 368 |
3 |
| Bristol-myers Squibb Company | 5080 |
2 |
| Janssen Pharmaceutica N.V. | 3839 |
2 |
| Takeda Pharmaceutical Company Limited | 2961 |
2 |
| Aventis Pharma S.A. | 129 |
2 |
| Cambridge Enterprise Limited | 1096 |
2 |
| Chubu University Educational Foundation | 90 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
2 |
| Draths Corporation | 4 |
2 |
| Seikagaku Corporation | 192 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
2 |
| Lunella Biotech, Inc. | 93 |
2 |
| Novartis AG | 11238 |
1 |
| F. Hoffmann-La Roche AG | 7958 |
1 |
| The Regents of the University of California | 18943 |
1 |
| Merck Sharp & Dohme Corp. | 2247 |
1 |
| Boehringer Ingelheim International GmbH | 4629 |
1 |
| Astellas Pharma Inc. | 1145 |
1 |
| Other owners | 23 |